|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 20418 |
FusionGeneSummary for LUC7L_SLC27A5 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: LUC7L_SLC27A5 | Fusion gene ID: 20418 | Hgene | Tgene | Gene symbol | LUC7L | SLC27A5 | Gene ID | 55692 | 10998 |
| Gene name | LUC7 like | solute carrier family 27 member 5 | |
| Synonyms | LUC7B1|Luc7|SR+89|hLuc7B1 | ACSB|ACSVL6|BACS|BAL|FACVL3|FATP-5|FATP5|VLACSR|VLCS-H2|VLCSH2 | |
| Cytomap | 16p13.3 | 19q13.43 | |
| Type of gene | protein-coding | protein-coding | |
| Description | putative RNA-binding protein Luc7-like 1putative SR protein LUC7B1sarcoplasmic reticulum protein LUC7B1 | bile acyl-CoA synthetaseBA-CoA ligaseVLACS-relatedbile acid-CoA ligasecholate--CoA ligasefatty acid transport protein 5fatty-acid-Coenzyme A ligase, very long-chain 3solute carrier family 27 (fatty acid transporter), member 5very long-chain acyl-C | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q9NQ29 | Q9Y2P5 | |
| Ensembl transtripts involved in fusion gene | ENST00000293872, ENST00000337351, ENST00000397783, ENST00000397780, ENST00000494366, | ENST00000594786, ENST00000599700, ENST00000263093, ENST00000601355, | |
| Fusion gene scores | * DoF score | 9 X 9 X 7=567 | 3 X 2 X 3=18 |
| # samples | 12 | 3 | |
| ** MAII score | log2(12/567*10)=-2.24031432933371 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: LUC7L [Title/Abstract] AND SLC27A5 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | SLC27A5 | GO:0000038 | very long-chain fatty acid metabolic process | 10479480 |
| Tgene | SLC27A5 | GO:0006699 | bile acid biosynthetic process | 11980911 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | BLCA | TCGA-4Z-AA87-01A | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000293872 | ENST00000594786 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000293872 | ENST00000599700 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000293872 | ENST00000263093 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000293872 | ENST00000601355 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000337351 | ENST00000594786 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000337351 | ENST00000599700 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000337351 | ENST00000263093 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000337351 | ENST00000601355 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000397783 | ENST00000594786 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000397783 | ENST00000599700 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000397783 | ENST00000263093 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000397783 | ENST00000601355 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000397780 | ENST00000594786 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000397780 | ENST00000599700 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000397780 | ENST00000263093 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5CDS-intron | ENST00000397780 | ENST00000601355 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5UTR-intron | ENST00000494366 | ENST00000594786 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5UTR-intron | ENST00000494366 | ENST00000599700 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5UTR-intron | ENST00000494366 | ENST00000263093 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
| 5UTR-intron | ENST00000494366 | ENST00000601355 | LUC7L | chr16 | 270648 | - | SLC27A5 | chr19 | 59012777 | - |
Top |
FusionProtFeatures for LUC7L_SLC27A5 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| LUC7L | SLC27A5 |
| May bind to RNA via its Arg/Ser-rich domain.{ECO:0000269|PubMed:11170747}. | Acyl-CoA synthetase involved in bile acid metabolism.Proposed to catalyze the first step in the conjugation of C24 bileacids (choloneates) to glycine and taurine before excretion intobile canaliculi by activating them to their CoA thioesters. Seemsto activate secondary bile acids entering the liver from theenterohepatic circulation. In vitro, also activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27precursor of cholic acid deriving from the de novo synthesis fromcholesterol. {ECO:0000269|PubMed:10749848,ECO:0000269|PubMed:11980911}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for LUC7L_SLC27A5 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for LUC7L_SLC27A5 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| LUC7L | RNPS1, NFKBIL1, FAM173A, USP50, TADA2A, CALM1, JMJD6, TCERG1, GADD45G, BARD1, CHERP, CTNNBL1, LUC7L, FBXO25, PRDX1, SRPK2, SRPK1, CLK2, SRPK3, PRMT5, CCDC8, SUZ12, EAF1, TRA2A, ZRANB2, LUC7L2, RBM27, RBM26, ZFP91, MRPL46, EIF2B1, ZC3H18, NKAP, BCLAF1, THRAP3, RECQL4, PRPF4B, C1QBP, SRRM2, FXR1, PTCD3, ZNF638, RBM23, GPATCH8, MRPS27, U2AF2, NRD1, UBE2O, LSM14B, SRRM1, CMAS, PPIG, PNN, VANGL1, ZCCHC8, LBR, DDX50, MRPS5, RBBP6, CSNK2A2, RBM25, MRPS9, SRRT, LARP1, CLK3, PRPF40A, CSNK2A1, PSME3, LUC7L3, TNPO3, RNMTL1, RBM7, SRSF11, MRPS22, MEPCE, CASC3, ACIN1, SCAF4, PHF10, RNASEH1, NKTR, CLASRP, SETD2, FTL, PRPF38B, MRS2, CPSF7, KBTBD6, VANGL2, MKRN1, YY1AP1, CHCHD2P9, SRSF10, SRSF8, PRRC2A, IBA57, HNRNPR, SF3B3, SNRNP70, SNRPD1, SNRPD2, SNRPD3, SYNCRIP, NTRK1, XPO1, NLRP3, SNW1, CDC5L, NANOG, RC3H1, CHCHD10, MRPL52, SRSF1, NCBP1, MRPL35, ZC3H14, INO80B, DLST, PDHA1, FOXA1, G3BP1 | SLC27A5 | HNRNPD |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LUC7L_SLC27A5 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LUC7L_SLC27A5 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|